Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jul 14, 1998	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000905718-98-000306.pdf 0000905718-98-000306.rtf
Aug 14, 1998	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001050929-98-000084.pdf 0001050929-98-000084.rtf
Oct 23, 1998	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001050929-98-000092.pdf 0001050929-98-000092.rtf
Nov 17, 1998	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001050929-98-000102.pdf 0001050929-98-000102.rtf
Nov 23, 1998	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001050929-98-000109.pdf 0001050929-98-000109.rtf
Feb 17, 1999	8-K	Report of unscheduled material events or corporate event	View HTML 0000930661-99-000293.pdf 0000930661-99-000293.rtf
Feb 17, 1999	NT 10-Q	Notification that form type 10-Q will be submitted late	View HTML 0000930661-99-000294.pdf 0000930661-99-000294.rtf
Feb 19, 1999	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000930661-99-000322.pdf 0000930661-99-000322.rtf
Apr 26, 1999	10-K/A	Amendment to a previously filed 10-K	View HTML 0000950134-99-003248.pdf 0000950134-99-003248.rtf
Apr 26, 1999	10-KT	Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act	View HTML 0000950134-99-003249.pdf 0000950134-99-003249.rtf